Since, experimental studies have demonstrated that PDE5 inhibitors, improve endothelial function [47], and reduce remarkably the infarct size in rat model of myocardial infarction [48,49], it is appealing to assume that these inhibitors may possess nephroprotective effects in AKI setting too, including contrast-induced renal injury. Here, PDE5A is linked to myocardial infarction.